MEGAN SEVILLA: Open Payments
NPI 1922635036 · PARMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60,921 in 281 payments from 23 companies in 2025. Trend: 2023 $14,108 · 2024 $55,598 · 2025 $60,921
Speaker / faculty: $50,070Travel & lodging: $5,605Food & beverage: $5,057Education: $190
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 47 | $20,492 |
| Lilly USA, LLC | 41 | $18,982 |
| GENZYME CORPORATION | 34 | $18,554 |
| ABBVIE INC. | 30 | $504 |
| UCB, Inc. | 16 | $356 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $348 |
| Galderma Laboratories, L.P. | 16 | $333 |
| Incyte Corporation | 14 | $224 |
| PFIZER INC. | 15 | $177 |
| Regeneron Healthcare Solutions, Inc. | 11 | $167 |
Products named: TREMFYA, DUPIXENT, EBGLYSS, Bimzelx, NEMLUVIO, RINVOQ, OPZELURA, SKYRIZI.
Industry payments across OH — which companies pay providers there.
